title: [Intravitreal Bevacizumab injections in a child with choroidal neovascularization--case report].
abstract: A healthy 11 year old boy with active choroidal neovascularization (CNV) was referred to the Department of Ophthalmology in Wroclaw for unilateral visual deterioration from 2 weeks. The best-corrected visual acuity was counting fingers from 4 meters. Boy was successfully treated with three intravitreal injections of bevacizumab. Intravitreal bevacizumab was well tolerated, choroidal neovascularization involuted, and best-corrected visual acuity improved to 20/32. The boy remained stable for 6 months after injections.
authors.affiliation: Katedry i Kliniki Okulistyki Akademii Medycznej we Wrocławiu. p_krzyzanowska@wp.pl
authors.forename: Patrycja
authors.initials: P
authors.lastname: Krzyzanowska-Berkowska
authors.forename: Anna
authors.initials: A
authors.lastname: Barć
authors.forename: Jolanta
authors.initials: J
authors.lastname: Oficjalska
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002648:Child; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D041623:Tomography, Optical Coherence / Q000379:methods; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab